These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. NT-proB natriuretic peptide, risk factors and asymptomatic left ventricular dysfunction: results of the SCReening Evaluation of the Evolution of New Heart Failure study (SCREEN-HF). McGrady M, Reid CM, Shiel L, Wolfe R, Boffa U, Liew D, Campbell DJ, Prior D, Stewart S, Krum H. Int J Cardiol; 2013 Oct 30; 169(2):133-8. PubMed ID: 24080362 [Abstract] [Full Text] [Related]
5. Prevalence of preclinical and clinical heart failure in the elderly. A population-based study in Central Italy. Mureddu GF, Agabiti N, Rizzello V, Forastiere F, Latini R, Cesaroni G, Masson S, Cacciatore G, Colivicchi F, Uguccioni M, Perucci CA, Boccanelli A, PREDICTOR Study Group. Eur J Heart Fail; 2012 Jul 30; 14(7):718-29. PubMed ID: 22562498 [Abstract] [Full Text] [Related]
6. [Screening of asymptomatic left ventricular systolic dysfunction in a population sample at high cardiovascular risk in Lombardy (Italy): the DAVID-Berg study]. Gavazzi A, De Maria R, Grosu A, Iacovoni A, Fontana A, Gori M, Ferrari P, Canova P, Calabrese A, Filippi A, Rutili MR, Donzelli L, Parolini M, Senni M. G Ital Cardiol (Rome); 2014 May 30; 15(5):313-22. PubMed ID: 25002172 [Abstract] [Full Text] [Related]
7. Population-based detection of systolic and diastolic dysfunction with amino-terminal pro-B-type natriuretic peptide. Abhayaratna WP, Marwick TH, Becker NG, Jeffery IM, McGill DA, Smith WT. Am Heart J; 2006 Nov 30; 152(5):941-8. PubMed ID: 17070165 [Abstract] [Full Text] [Related]
9. Predictive value of B-type natriuretic peptides in detecting latent left ventricular diastolic dysfunction in beta-thalassemia major. Kremastinos DT, Hamodraka E, Parissis J, Tsiapras D, Dima K, Maisel A. Am Heart J; 2010 Jan 30; 159(1):68-74. PubMed ID: 20102869 [Abstract] [Full Text] [Related]
10. [Asymptomatic ischemic heart dysfunction, echocardiographic changes and NT-proBNP during 2-years observation]. Skrzypek A, Nessler J. Przegl Lek; 2014 Jan 30; 71(7):378-83. PubMed ID: 25338333 [Abstract] [Full Text] [Related]
11. Prognostic value of N-terminal pro-type-B natriuretic peptide and Doppler left ventricular diastolic variables in patients with chronic systolic heart failure stabilized by therapy. Dini FL, Conti U, Fontanive P, Andreini D, Panicucci E, De Tommasi SM. Am J Cardiol; 2008 Aug 15; 102(4):463-8. PubMed ID: 18678307 [Abstract] [Full Text] [Related]
16. SCReening Evaluation of the Evolution of New Heart Failure Study (SCREEN-HF): early detection of chronic heart failure in the workplace. Boffa U, McGrady M, Reid CM, Shiel L, Wolfe R, Liew D, Campbell DJ, Stewart S, Krum H. Aust Health Rev; 2017 May 15; 41(2):121-126. PubMed ID: 27096227 [Abstract] [Full Text] [Related]
17. Plasma NT-proBNP levels associated with cardiac structural abnormalities in asymptomatic health examinees with preserved ejection fraction: a retrospective cross-sectional study. Nah EH, Kim SY, Cho S, Kim S, Cho HI. BMJ Open; 2019 Apr 20; 9(4):e026030. PubMed ID: 31005928 [Abstract] [Full Text] [Related]
18. N-terminal-probrain natriuretic peptide and echocardiography in patients with systolic heart failure. Al-Meslmani BM, Fahoum SK, Shamia MG. Saudi Med J; 2005 Nov 20; 26(11):1695-8. PubMed ID: 16311650 [Abstract] [Full Text] [Related]
19. Beneficial Effect on Surrogate Markers of Heart Failure with Bisoprolol Up-Titration to Recommended Targets in Korean Patients with Heart Failure and Left Ventricular Systolic Dysfunction. Han SW, Choi SW, Ryu KH, Kim HJ, Kim SH, Shim WJ, Cha TJ, Choi DJ, Kim YJ, Yoo BS, Kim JH, Hwang KK, Jeon H, Shin MS. Cardiovasc Ther; 2016 Jun 20; 34(3):172-9. PubMed ID: 27003232 [Abstract] [Full Text] [Related]